Influence of mitochondrion-toxic agents on the cardiovascular system

Regulatory Toxicology and Pharmacology

Volumn 67, Issue 3, 2013, Pages 434-445

  Finsterer, Josef ^a   Ohnsorge, Peter ^b  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^b European Academy for Environmental Medicine eV   (Germany)

Author keywords

Arrhythmias; Cardiomyopathy; Drugs; Intoxication; Medication; Mitochondrial dysfunction; Oxidative phosphorylation; Respiratory chain

Indexed keywords

ALCOHOL; ALUMINUM PHOSPHIDE; ANTHRACYCLINE; ARSENIC TRIOXIDE; BORTEZOMIB; BUTENOLIDE; CADMIUM; CALCIUM ION; CARBON MONOXIDE; CARDIAC GLYCOSIDE; CARDIOTOXIN; CISPLATIN; COCAINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIGITOXIN; DOXORUBICIN; FLUOROURACIL; IMATINIB; ISOPRENALINE; LAMOTRIGINE; LIDOCAINE; MALATHION; MEDIHALER; MERCURY; MICROCYSTIN; MITOXANTRONE; NITROPRUSSIDE SODIUM; PIVALIC ACID; TRASTUZUMAB; UNCLASSIFIED DRUG; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; ARTICLE; BREAST CANCER; BRONCHOSPASM; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CANCER COMBINATION CHEMOTHERAPY; CARDIOMYOPATHY; CARDIOTOXICITY; CARDIOVASCULAR RESPONSE; CELL FUNCTION; CHRONIC MYELOID LEUKEMIA; COLON CANCER; CORONARY ARTERY DISEASE; DIGESTIVE SYSTEM CANCER; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG DOSE INCREASE; DRUG RESPONSE; ECG ABNORMALITY; ENERGY YIELD; EPILEPSY; HEART ARRHYTHMIA; HEART FAILURE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; LEUKEMIA; LIVER CANCER; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MULTIPLE SCLEROSIS; MYOCARDITIS; NONHUMAN; PLASMACYTOMA; PRIORITY JOURNAL; QT PROLONGATION; SUPRAVENTRICULAR TACHYCARDIA; SYSTOLIC DYSFUNCTION; TAKOTSUBO CARDIOMYOPATHY; THERMOGENESIS;

ANIMALIA;

ARRHYTHMIAS; CARDIOMYOPATHY; DRUGS; INTOXICATION; MEDICATION; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE PHOSPHORYLATION; RESPIRATORY CHAIN;

ANIMALS; APOPTOSIS; CARDIOTOXINS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; ENERGY METABOLISM; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA, HEART; OXIDATIVE STRESS;

EID: 84887827936     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2013.09.002     Document Type: Article

References (130)

1. Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., Walter, P., 2008. Apoptosis: programmed cell death eliminates unwanted cells. In: Molecular Biology of the Cell. Garland Science, fifth ed. p. 1115. ISBN 978-0-8153-4105-5.5b.
2. Ananya R., Subeena S., Kumar D.A., Kumar D.T., Kumar M.S. Oxidative stress and histopathological changes in the heart following oral lindane (gamma hexachlorohexane) administration in rats. Med. Sci. Monit. 2005, 11:BR325-BR329.
3. Ascensão A., Oliveira P.J., Magalhães J. Exercise as a beneficial adjunct therapy during Doxorubicin treatment-role of mitochondria in cardioprotection. Int. J. Cardiol. 2012, 156(1):4-10.
4. Asiri Y.A. Probucol attenuates cyclophosphamide-induced oxidative apoptosis, p53 and Bax signal expression in rat cardiac tissues. Oxid. Med. Cell Longev. 2010, 3:308-316.
5. Azim H., Azim H.A., Escudier B. Trastuzumab versus lapatinib: the cardiac side of the story. Cancer Treat. Rev. 2009, 35:633-638.
6. Balcarek K., Venhoff N., Deveaud C., Beauvoit B., Bonnet J., Kirschner J., Venhoff A.C., Lebrecht D., Walker U.A. Role of pyrimidine depletion in the mitochondrial cardiotoxicity of nucleoside analogue reverse transcriptase inhibitors. J. Acquir. Immune Defic. Syndr. 2010, 55:550-557.
7. Barbey J.T., Pezzullo J.C., Soignet S.L. Effect of arsenic trioxide on QT interval in patients with advanced malignancies. J. Clin. Oncol. 2003, 21:3609-3615.
8. Barclay B.J., DeHaan C.L., Hennig U.G., Iavorovska O., von Borstel R.W., von Borstel R.C. A rapid assay for mitochondrial DNA damage and respiratory chain inhibition in the yeast Saccharomyces cerevisiae. Environ. Mol. Mutagen. 2001, 38:153-158.
9. Bartel L.C., Montalto de Mecca M., Fanelli S.L., Rodriguez de Castro C., Diaz E.G., Castro J.A. Early nifurtimox-induced biochemical and ultrastructural alterations in rat heart. Hum. Exp. Toxicol. 2007, 26:781-788.
10. Bertolet B.D., Freund G., Martin C.A., Perchalski D.L., Williams C.M., Pepine C.J. Unrecognized left ventricular dysfunction in an apparently healthy cocaine abuse population. Clin. Cardiol. 1990, 13:323-328.
11. Bhayana V., Alto L.E., Dhalla N.S. Effects of pentobarbital and pentothal on rat heart contractile force and oxidative phosphorylation activities. Gen. Pharmacol. 1980, 11:375-377.
12. Brighton C.T., Hunt R.M. Mitochondrial calcium and its role in calcification. Clin. Orthop. Relat. Res. 1974, 100:406.
13. Broderick T.L. Hypocarnitinaemia induced by sodium pivalate in the rat is associated with left ventricular dysfunction and impaired energy metabolism. Drugs R D 2006, 7:153-161.
14. Campbell J.W. Mitochondrial ammonia metabolism and the proton-neutral theory of hepatic ammonia detoxication. J. Exp. Zool. 1997, 278:308-321.
15. Carvalho F.S., Burgeiro A., Garcia R., Moreno A.J., Carvalho R.A., Oliveira P.J. Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy. Med. Res. Rev. 2013, 10.1002/med.21280.
16. Castel M., Despas F., Modesto A., Gales C., Honton B., Galinier M., Senard J.M., Pathak A. Cardiotoxicity of chemotherapies. Presse Med. 2013, 42:26-39.
17. Chen N., Chawla S.P., Chiorean E.G., Read W.L., Gorbaty M., Mita A.C., Yung L., Bryan P., McNally R., Renschler M.F., Sharma S. Phase I study to assess the pharmacokinetics and the effect on cardiac repolarization of amrubicin and amrubicinol in patients with advanced solid tumors. Cancer Chemother. Pharmacol. 2013, 71:1083-1094.
18. Chiusa M., Timolati F., Perriard J.C., Suter T.M., Zuppinger C. Sodium nitroprusside induces cell death and cytoskeleton degradation in adult rat cardiomyocytes in vitro: implications for anthracycline-induced cardiotoxicity. Eur. J. Histochem. 2012, 56:e15.
19. Chuang G.C., Yang Z., Westbrook D.G., Pompilius M., Ballinger C.A., White C.R., Krzywanski D.M., Postlethwait E.M., Ballinger S.W. Pulmonary ozone exposure induces vascular dysfunction, mitochondrial damage, and atherogenesis. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009, 297:L209-16.
20. Clark, T.A., Deniset, J.F., Heyliger, C.E., Pierce, G.N., 2013. Alternative therapies for diabetes and its cardiac complications: role of vanadium. Heart Fail. Rev. (in press).
21. Coşkun B., Cömelekoǧlu U., Polat A., Kaymaz F.F. Evaluation of the toxic effects of cypermethrin inhalation on the frog heart. Ecotoxicol. Environ. Saf. 2004, 57:220-225.
22. Farthing D., Gehr L., Karnes H.T., Sica D., Gehr T., Larus T., Farthing C., Xi L. Effects of salicylic acid on post-ischaemic ventricular function and purine efflux in isolated mouse hearts. Biomarkers 2007, 12:623-634.
23. Gharanei M., Hussain A., Janneh O., Maddock H.L. Doxorubicin induced myocardial injury is exacerbated following ischaemic stress via opening of the mitochondrial permeability transition pore. Toxicol. Appl. Pharmacol. 2013, 268:149-156.
24. Golomb E., Schneider A., Houminer E., Dunnick J., Kissling G., Borman J.B., Nyska A., Schwalb H. Occult cardiotoxicity: subtoxic dosage of Bis(2-chloroethoxy)methane impairs cardiac response to simulated ischemic injury. Toxicol. Pathol. 2007, 35:383-387.
25. Graf B.M. The cardiotoxicity of local anesthetics: the place of ropivacaine. Curr. Top. Med. Chem. 2001, 1:207-214.
26. Grazette L.P., Boecker W., Matsui T., Semigran M., Force T.L., Hajjar R.J., Rosenzweig A. Inhibition of ErbB2 causes mitochondrial dysfunction in cardiomyocytes: implications for herceptin-induced cardiomyopathy. J. Am. Coll. Cardiol. 2004, 44:2231-2238.
27. Green, D., 2011. Means to an End: Apoptosis and other Cell Death Mechanisms. Cold Spring Harbor, Cold Spring Harbor Laboratory Press, NY. ISBN 978-0-87969-888-1.
28. Grivicich I., Regner A., da Rocha A.B., Grass L.B., Alves P.A., Kayser G.B., Schwartsmann G., Henriques J.A. Irinotecan/5-fluorouracil combination induces alterations in mitochondrial membrane potential and caspases on colon cancer cell lines. Oncol. Res. 2005, 15:385-392.
29. Hollenberg S.M. Vasodilators in acute heart failure. Heart Fail. Rev. 2007, 12:143-147.
30. Houston M.C. Role of mercury toxicity in hypertension, cardiovascular disease, and stroke. J. Clin. Hypertens. (Greenwich) 2011, 13:621-627.
31. Hsiao C.J., Li T.K., Chan Y.L., Hsin L.W., Liao C.H., Lee C.H., Lyu P.C., Guh J.H. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers. Biochem. Pharmacol. 2008, 75:847-856.
32. Huang Q.Y., Fang C.W., Huang H.Q. Alteration of heart tissue protein profiles in acute cadmium-treated scallops Patinopecten yessoensis. Arch. Environ. Contam. Toxicol. 2011, 60:90-98.
33. Jeremic B., Jevremovic S., Djuric L., Mijatovic L. Cardiotoxicity during chemotherapy treatment with 5-fluorouracil and cisplatin. J. Chemother. 1990, 2:264-267.
34. Jungsuwadee P., Nithipongvanitch R., Chen Y., Oberley T.D., Butterfield D.A., Clair D.K., Vore M. Mrp1 localization and function in cardiac mitochondria after doxorubicin. Mol. Pharmacol. 2009, 75:1117-1126.
35. Kalender S., Kalender Y., Ates A., Yel M., Olcay E., Candan S. Protective role of antioxidant vitamin E and catechin on idarubicin-induced cardiotoxicity in rats. Braz. J. Med. Biol. Res. 2002, 35:1379-1387.
36. Kamiński M.M., Röth D., Krammer P.H., Gülow K. Mitochondria as Oxidative Signaling Organelles in T-cell Activation: physiological Role and Pathological Implications. Arch. Immunol. Ther. Exp. 2013.
37. Karam J.A. Apoptosis in Carcinogenesis and Chemotherapy 2009, Springer, Netherlands.
38. Kerkelä R., Grazette L., Yacobi R., Iliescu C., Patten R., Beahm C., Walters B., Shevtsov S., Pesant S., Clubb F.J., Rosenzweig A., Salomon R.N., Van Etten R.A., Alroy J., Durand J.B., Force T. Cardiotoxicity of the cancer therapeutic agent imatinib mesylate. Nat. Med. 2006, 12:908-916.
39. Kibayashi M., Nagao M., Chiba S. Influence of valproic acid on the expression of various acyl-CoA dehydrogenases in rats. Pediatr. Int. 1999, 41:52-60.
40. Kingwell E., Koch M., Leung B., Isserow S., Geddes J., Rieckmann P., Tremlett H. Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS. Neurology 2010, 74:1822-1826.
41. Kluza J., Marchetti P., Gallego M.A., Lancel S., Fournier C., Loyens A., Beauvillain J.C., Bailly C. Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells. Oncogene 2004, 23:7018-7030.
42. Kong J.Y., Rabkin S.W. Lovastatin does not accentuate but is rather additive to palmitate-induced apoptosis in cardiomyocytes. Prostaglandins Leukot. Essent. Fatty Acids 2002, 67:293-302.
43. Kong H.L., Li Z.Q., Zhao Y.J., Zhao S.M., Zhu L., Li T., Fu Y., Li H.J. Ginsenoside Rb1 protects cardiomyocytes against CoCl2-induced apoptosis in neonatal rats by inhibiting mitochondria permeability transition pore opening. Acta Pharmacol. Sin. 2010, 31:687-695.
44. Le Page E., Leray E. Edan G; French Mitoxantrone Safety Group. Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective study. Mult. Scler. 2011, 17:867-875.
45. Lei W., Wang L., Liu D., Xu T., Luo J. Histopathological and biochemical alternations of the heart induced by acute cadmium exposure in the freshwater crab Sinopotamon yangtsekiense. Chemosphere 2011, 84:689-694.
46. Liu T., Brown D.A., O'Rourke B. Role of mitochondrial dysfunction in cardiac glycoside toxicity. J. Mol. Cell. Cardiol. 2010, 49:728-736.
47. Liu Y., Zhou L., Xu H.F., Yan L., Ding F., Hao W., Cao J.M., Gao X. A preliminary experimental study on the cardiac toxicity of glutamate and the role of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor in rats. Chin. Med. J. (Engl) 2013, 126:1323-1332.
48. Lopes A.C., Villa N., Medeiros L.O., Sustovich D.R., Sasso W.D. Some ultrastructural aspects of the cardiac muscle of albino rat during the acute stress produced by formaldehyde (author's transl). Rev. Bras. Pesqui. Med. Biol. 1979, 12:81-88.
49. Lu F., Xing J., Zhang X., Dong S., Zhao Y., Wang L., Li H., Yang F., Xu C., Zhang W. Exogenous hydrogen sulfide prevents cardiomyocyte apoptosis from cardiac hypertrophy induced by isoproterenol. Mol Cell Biochem 2013, 381:41-50.
50. Lu D., Ma Y., Zhang W., Bao D., Dong W., Lian H., Huang L., Zhang L. Knockdown of cytochrome P450 2E1 inhibits oxidative stress and apoptosis in the cTnT(R141W) dilated cardiomyopathy transgenic mice. Hypertension 2012, 60:81-89.
51. Lushnikova E.L., Nepomnyashchikh L.M., Sviridov E.A., Klinnikova M.G. Ultrastructural signs of cyclophosphamide-induced damage to cardiomyocytes. Bull. Exp. Biol. Med. 2008, 146:366-371.
52. Ma H., Jones K.R., Guo R., Xu P., Shen Y., Ren J. Cisplatin compromises myocardial contractile function and mitochondrial ultrastructure: role of endoplasmic reticulum stress. Clin. Exp. Pharmacol. Physiol. 2010, 37:460-465.
53. Marchini T., Magnani N., D'Annunzio V., Tasat D., Gelpi R.J., Alvarez S., Evelson P. Impaired cardiac mitochondrial function and contractile reserve following an acute exposure to environmental particulate matter. Biochim. Biophys. Acta 2013, 1830:2545-2552.
54. Marriott J.J., Miyasaki J.M., Gronseth G., O'Connor P.W. Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2010, 74:1463-1470.
55. McDonald T.E., Grinman M.N., Carthy C.M., Walley K.R. Endotoxin infusion in rats induces apoptotic and survival pathways in hearts. Am. J. Physiol. Heart Circ. Physiol. 2000, 279:H2053-H2061.
56. Mdaghri Y.A., Mossadeq A., Faroudy M., Sbihi A. Cardiac complications associated with organophosphate poisoning. Ann. Cardiol. Angeiol. (Paris) 2010, 59:114-117.
57. Meng Z., Liu Y. Cell morphological ultrastructural changes in various organs from mice exposed by inhalation to sulfur dioxide. Inhal. Toxicol. 2007, 19:543-551.
58. Meyer J.N., Leung M.C., Rooney J.P., Sendoel A., Hengartner M.O., Kisby G.E., Bess A.S. Mitochondria as a Target of Environmental Toxicants. Toxicol Sci 2013, 134:1-17.
59. Mikhleva L.M. Cadmium-related pathology in man. Arkh. Patol. 1988, 50:81-85.
60. Milutinović A., Zorc-Pleskovič R. Glycogen accumulation in cardiomyocytes and cardiotoxic effects after 3NPA treatment. Bosn. J. Basic Med. Sci. 2012, 12:15-19.
61. Mordente A., Meucci E., Silvestrini A., Martorana G.E., Giardina B. Anthracyclines and mitochondria. Adv. Exp. Med. Biol. 2012, 942:385-419.
62. Moreno-Sánchez R., Rodríguez-Enríquez S., Marín-Hernández A., Saavedra E. Energy metabolism in tumor cells. FEBS J. 2007, 274:1393-1418.
63. Morris P.D., Robinson T., Channer K.S. Reversible heart failure: toxins, tachycardiomyopathy and mitochondrial abnormalities. Postgrad. Med. J. 2012, 88:706-712.
64. Mouhaffel A.H., Madu E.C., Satmary W.A., Fraker T.D. Cardiovascular complications of cocaine. Chest 1995, 107:1426-1434.
65. Mozo J., Emre Y., Bouillaud F., Ricquier D., Criscuolo F. Thermoregulation: What Role for UCPs in Mammals and Birds?. Biosci. Rep. 2005, 25:227-249.
66. Murray T.J. The cardiac effects of mitoxantrone: do the benefits in multiple sclerosis outweigh the risks?. Expert Opin. Drug Saf. 2006, 5:265-274.
67. Nain S., Wojnarowicz C., Laarveld B., Olkowski A.A. Putative cardiotoxic compounds extracted from meat meal as a potential risk factor for the development of heart failure in fast-growing commercial broilers. Avian Pathol. 2008, 37:605-612.
68. N'guessan B.B., Sanchez H., Zoll J., Ribera F., Dufour S., Lampert E., Kindo M., Geny B., Ventura-Clapier R., Mettauer B. Oxidative capacities of cardiac and skeletal muscles of heart transplant recipients: mitochondrial effects of cyclosporin-A and its vehicle Cremophor-EL. Fundam. Clin. Pharmacol. 2012 Sep 14, 10.1111/fcp.12002.
69. Nowis D., Maczewski M., Mackiewicz U., Kujawa M., Ratajska A., Wieckowski M.R., Wilczyński G.M., Malinowska M., Bil J., Salwa P., Bugajski M., Wójcik C., Siński M., Abramczyk P., Winiarska M., Dabrowska-Iwanicka A., Duszyński J., Jakóbisiak M., Golab J. Cardiotoxicity of the anticancer therapeutic agent bortezomib. Am. J. Pathol. 2010, 176:2658-2668.
70. Ohnishi K., Yoshida H., Shigeno K., Nakamura S., Fujisawa S., Naito K., Shinjo K., Fujita Y., Matsui H., Sahara N., Takeshita A., Satoh H., Terada H., Ohno R. Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoring. Leukemia 2002, 16:617-622.
71. Ozturk M.A., Ozveren O., Cinar V., Erdik B., Oyan B. Takotsubo syndrome: an underdiagnosed complication of 5-fluorouracil mimicking acute myocardial infarction. Blood Coagul. Fibrinolysis 2013, 24:90-94.
72. Palmeira, C.M., Moreno, A.J. (Eds.) 2012. Mitochondrial Bioenergetics. Methods and Protocols. Springer Methods in Molecular Biology, Vol. 810. ISBN: 978-1-61779-381-3 (Print) 978-1-61779-382-0 (Online).
73. Peers C., Steele D.S. Carbon monoxide: a vital signalling molecule and potent toxin in the myocardium. J. Mol. Cell. Cardiol. 2012, 52:359-365.
74. Pentassuglia L., Timolati F., Seifriz F., Abudukadier K., Suter T.M., Zuppinger C. Inhibition of ErbB2/neuregulin signaling augments paclitaxel-induced cardiotoxicity in adult ventricular myocytes. Exp. Cell Res. 2007, 313:1588-1601.
75. Pereira G.C., Silva A.M., Diogo C.V., Carvalho F.S., Monteiro P., Oliveira P.J. Drug-induced cardiac mitochondrial toxicity and protection: from doxorubicin to carvedilol. Curr. Pharm. Des. 2011, 17:2113-2129.
76. Perfilova V.N., Ostrovskii O.V., Verovskii V.E., Popova T.A., Lebedeva S.A., Dib H. Effect of Citrocard on functional activity of cardiomyocyte mitochondria during chronic alcohol intoxication. Bull. Exp. Biol. Med. 2007, 143:341-343.
77. Perrotta I., Tripepi S. Ultrastructural alterations in the ventricular myocardium of the adult Italian newt (Lissotriton italicus) following exposure to nonylphenol ethoxylate. Micron 2012, 43:183-191.
78. Philips B., Madhavan S., James C., Tichnell C., Murray B., Needleman M., Bhonsale A., Nazarian S., Laurita K.R., Calkins H., Tandri H. High prevalence of catecholamine-facilitated focal ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ. Arrhythm. Electrophysiol. 2013, 6:160-166.
79. Pizzo P., Pozzan T. Mitochondria-endoplasmic reticulum choreography: structure and signaling dynamics". Trends Cell Biol. 2007, 17:511-517.
80. Possamai F.P., Fortunato J.J., Feier G., Agostinho F.R., Quevedo J. Wilhelm Filho D, Dal-Pizzol F. Oxidative stress after acute and sub-chronic malathion intoxication in Wistar rats. Environ. Toxicol. Pharmacol. 2007, 23:198-204.
81. Póvoa R., Cardoso S.H., Luna Filho B., Ferreira Filho C., Ferreira M., Ferreira C. Organophosphate poisoning and myocardial necrosis. Arq. Bras. Cardiol. 1997, 68:377-380.
82. Prince P.S., Sathya B. Pretreatment with quercetin ameliorates lipids, lipoproteins and marker enzymes of lipid metabolism in isoproterenol treated cardiotoxic male Wistar rats. Eur. J. Pharmacol. 2010, 635:142-148.
83. Pritsos C.A., Briggs L.A. Disruption of normal cellular bioenergetics in Balb/c mice by mitomycin C. Br. J. Cancer. Suppl. 1996, 27:S15-S18.
84. Qiu T., Xie P., Liu Y., Li G., Xiong Q., Hao L., Li H. The profound effects of microcystin on cardiac antioxidant enzymes, mitochondrial function and cardiac toxicity in rat. Toxicology 2009, 257:86-94.
85. Ramirez-Ortega M., Zarco G., Maldonado V., Carrillo J.F., Ramos P., Ceballos G., Melendez-Zajgla J., Garcia N., Zazueta C., Chanona J., Suarez J., Pastelin G. Is digitalis compound-induced cardiotoxicity, mediated through guinea-pig cardiomyocytes apoptosis?. Eur. J. Pharmacol. 2007, 566:34-42.
86. Razavi B.M., Hosseinzadeh H., Movassaghi A.R., Imenshahidi M., Abnous K. Protective effect of crocin on diazinon induced cardiotoxicity in rats in subchronic exposure. Chem. Biol. Interact. 2013, 203:547-555.
87. Riezzo I., Fiore C., De Carlo D., Pascale N., Neri M., Turillazzi E., Fineschi V. Side effects of cocaine abuse: multiorgan toxicity and pathological consequences. Curr. Med. Chem. 2012, 19:5624-5646.
88. Rockenfeller P., Ring J., Muschett V., Beranek A., Buettner S., Carmona-Gutierrez D., Eisenberg T., Khoury C., Rechberger G., Kohlwein S.D., Kroemer G., Madeo F. Fatty acids trigger mitochondrion-dependent necrosis. Cell Cycle 2010, 9:2836-2842.
89. Rossato, L.G., Costa, V.M., de Pinho, P.G., Arbo, M.D., de Freitas, V., Vilain, L., de Lourdes Bastos, M., Palmeira, C., Remião, F. The metabolic profile of mitoxantrone and its relation with mitoxantrone-induced cardiotoxicity. Arch. Toxicol. (in press).
90. Rossier M.F. T channels and steroid biosynthesis: in search of a link with mitochondria. Cell Calcium 2006, 40:155-164.
91. Ruigrok T.J., Slade A.M., van der Meer P., de Moes D., Sinclair D.M., Poole-Wilson P.A., Meijler F.L. Different effects of thiopental in severe hypoxia, total ischemia, and low-flow ischemia in rat heart muscle. Anesthesiology 1985, 63:172-178.
92. Sáez C.G., Olivares P., Pallavicini J., Panes O., Moreno N., Massardo T., Mezzano D., Pereira J. Increased number of circulating endothelial cells and plasma markers of endothelial damage in chronic cocaine users. Thromb. Res. 2011, 128:e18-23.
93. Salvatorelli E., Menna P., Gonzalez Paz O., Surapaneni S, Aukerman S.L., Chello M., Covino E., Sung V., Minotti G. Pharmacokinetic characterization of amrubicin cardiac safety in an ex vivo human myocardial strip model. II. Amrubicin shows metabolic advantages over doxorubicin and epirubicin. J. Pharmacol. Exp. Ther. 2012, 341:474-483.
94. Santucci L., Mencarelli A., Renga B., Ceccobelli D., Pasut G., Veronese F.M., Distrutti E., Fiorucci S. Cardiac safety and antitumoral activity of a new nitric oxide derivative of pegylated epirubicin in mice. Anticancer Drugs 2007, 18:1081-1091.
95. Sayed-Ahmed M.M., Salman T.M., Gaballah H.E., Abou El-Naga S.A., Nicolai R., Calvani M. Propionyl-l-carnitine as protector against adriamycin-induced cardiomyopathy. Pharmacol. Res. 2001, 43:513-520.
96. Sayed-Ahmed M.M., Darweesh A.Q., Fatani A.J. Carnitine deficiency and oxidative stress provoke cardiotoxicity in an ifosfamide-induced Fanconi syndrome rat model. Oxid. Med. Cell Longev. 2010, 3:266-274.
97. Schwarzlander M., Logan D.C., Johnston I.G., Jones N.S., Meyer A.J., Fricker M.D., Sweetlove L.J. "Pulsing of membrane potential in individual mitochondria: a stress-induced mechanism to regulate respiratory bioenergetics in arabidopsis. Plant Cell 2012, 24:1188-1201.
98. Shafiee H., Mohammadi H., Rezayat S.M., Hosseini A., Baeeri M., Hassani S., Mohammadirad A., Bayrami Z., Abdollahi M. Prevention of malathion-induced depletion of cardiac cells mitochondrial energy and free radical damage by a magnetic magnesium-carrying nanoparticle. Toxicol. Mech. Methods 2010, 20:538-543.
99. Shemarova I.V., Korotkov S.M., Nesterov V.P. Influence of oxidative processes in mitochondria on contractility of the frog Rana temporaria heart muscle. Effects of cadmium. Zh. Evol. Biokhim. Fiziol. 2011, 47:306-310.
100. Siddaiah L., Adhyapak S., Jaydev S., Shetty G., Varghese K., Patil C., Iyengar S. Intra-aortic balloon pump in toxic myocarditis due to aluminum phosphide poisoning. J. Med. Toxicol. 2009, 5:80-83.
101. Silva-Platas C., García N., Fernández-Sada E., Dávila D., Hernández-Brenes C., Rodríguez D., García-Rivas G. Cardiotoxicity of acetogenins from Persea americana occurs through the mitochondrial permeability transition pore and caspase-dependent apoptosis pathways. J. Bioenerg. Biomembr. 2012, 44:461-471.
102. Simbre V.C., Duffy S.A., Dadlani G.H., Miller T.L., Lipshultz S.E. Cardiotoxicity of cancer chemotherapy: implications for children. Paediatr. Drugs 2005, 7:187-202.
103. Soares M.P., Pavarini S.P., Adrien Mde L., Quevedo Pde S., Schild A.L., Peixoto P.V., da Cruz C.E., Driemeier D. Amorimia exotropica poisoning as a presumptive cause of myocardial fibrosis in cattle. J. Vet. Diagn. Invest. 2011, 23:1226-1229.
104. Soares S.S., Gutiérrez-Merino C., Aureliano M. Mitochondria as a target for decavanadate toxicity in Sparus aurata heart. Aquat. Toxicol. 2007, 83:1-9.
105. Sorrentino M.F., Kim J., Foderaro A.E., Truesdell A.G. 5-fluorouracil induced cardiotoxicity: review of the literature. Cardiol. J. 2012, 19:453-458.
106. Spallarossa P., Altieri P., Pronzato P., Aloi C., Ghigliotti G., Barsotti A., Brunelli C. Sublethal doses of an anti-erbB2 antibody leads to death by apoptosis in cardiomyocytes sensitized by low prosenescent doses of epirubicin: the protective role of dexrazoxane. J. Pharmacol. Exp. Ther. 2010, 332:87-96.
107. Spedding M., Tillement J.P., Morin D., Le Ridant A. Medicines interacting with mitochondria: anti-ischemic effects of trimetazidine. Therapie 1999, 54:627-635.
108. Stěrba M., Popelová O., Lenčo J., Fučíková A., Brčáková E., Mazurová Y., Jirkovský E., Simůnek T., Adamcová M., Mičuda S., Stulík J., Geršl V. Proteomic insights into chronic anthracycline cardiotoxicity. J. Mol. Cell. Cardiol. 2011, 50:849-862.
109. Stöllberger C., Höftberger R., Finsterer J. Lamotrigine-trigged obstructive hypertrophic cardiomyopathy, epilepsy and metabolic myopathy. Int. J. Cardiol. 2011, 149:e103-5.
110. Suliman H.B., Welty-Wolf K.E., Carraway M., Tatro L., Piantadosi C.A. Lipopolysaccharide induces oxidative cardiac mitochondrial damage and biogenesis. Cardiovasc. Res. 2004, 64:279-288.
111. Suput D., Zorc-Pleskovic R., Petrovic D., Milutinović A. Cardiotoxic injury caused by chronic administration of microcystin-YR. Folia Biol. (Praha) 2010, 56:14-18.
112. Sweet S., Singh G. Changes in mitochondrial mass, membrane potential, and cellular adenosine triphosphate content during the cell cycle of human leukemic (HL-60) cells. J. Cell. Physiol. 1999, 180:91-96.
113. Swegert C.V., Dave K.R., Katyare S.S. Effect of aluminium-induced Alzheimer like condition on oxidative energy metabolism in rat liver, brain and heart mitochondria. Mech. Ageing Dev. 1999, 112:27-42.
114. Szponar J., Kołodziej M., Majewska M., Zaleski K., Lewandowska-Stanek H. Myocardial injury in the course of carbon monoxide poisoning. Przegl. Lek. 2012, 69:528-534.
115. Tan X., Wang D.B., Lu X., Wei H., Zhu R., Zhu S.S., Jiang H., Yang Z.J. Doxorubicin induces apoptosis in H9c2 cardiomyocytes: role of overexpressed eukaryotic translation initiation factor 5A. Biol. Pharm. Bull. 2010, 33:1666-1672.
116. Tokarska-Schlattner M., Zaugg M., Zuppinger C., Wallimann T., Schlattner U. New insights into doxorubicin-induced cardiotoxicity: the critical role of cellular energetics. J. Mol. Cell. Cardiol. 2006, 41:389-405.
117. Tsuchiya H., Mizogami M., Ueno T., Shigemi K. Cardiotoxic local anesthetics increasingly interact with biomimetic membranes under ischemia-like acidic conditions. Biol. Pharm. Bull. 2012, 35:988-992.
118. Vergnenègre A., Thomas P., Robinet G., Pibarot M., Paillotin D., Vernejoux J.M., Thiberville L., Lena H., Kleisbauer J.P., Gimonet J.F. High-dose ifosfamide in patients with stage IV non-small cell lung cancer: phase II trial from the Groupe français de pneumo-cancérologie (GFPC). Bull. Cancer 1999, 86:1017-1021.
119. Vineetha V.P., Prathapan A., Soumya R.S., Raghu K.G. Arsenic trioxide toxicity in H9c2 myoblasts-damage to cell organelles and possible amelioration with Boerhavia diffusa. Cardiovasc. Toxicol. 2013, 13:123-137.
120. Voet D., Voet J.G., Pratt C.W. Fundamentals of Biochemistry 2006, John Wiley and Sons, Inc., p. 547, ISBN 0-471-21495-7. second ed.
121. Walker U.A. Lactic acidosis in HIV-patients-diagnosis and treatment. MMW Fortschr Med 2004, 26(146):65-67. Spec no. 1.
122. Wang G.W., Guo Y., Vondriska T.M., Zhang J., Zhang S., Tsai L.L., Zong N.C., Bolli R., Bhatnagar A., Prabhu S.D. Acrolein consumption exacerbates myocardial ischemic injury and blocks nitric oxide-induced PKCepsilon signaling and cardioprotection. J. Mol. Cell. Cardiol. 2008, 44:1016-1022.
123. Wang Y.M., Liu J.B., Peng S.Q. Effects of Fusarium mycotoxin butenolide on myocardial mitochondria in vitro. Toxicol. Mech. Methods 2009, 19:79-85.
124. Waseem M., Parvez S. Mitochondrial dysfunction mediated cisplatin induced toxicity: modulatory role of curcumin. Food Chem. Toxicol. 2013, 53:334-342.
125. Wei A.C., Liu T., Cortassa S., Winslow R.L., O'Rourke B. Mitochondrial Ca2+ influx and efflux rates in guinea pig cardiac mitochondria: low and high affinity effects of cyclosporine A. Biochim. Biophys. Acta 2011, 1813:1373-1381.
126. Will Y., Dykens J.A., Nadanaciva S., Hirakawa B., Jamieson J., Marroquin L.D., Hynes J., Patyna S., Jessen B.A. Effect of the multitargeted tyrosine kinase inhibitors imatinib, dasatinib, sunitinib, and sorafenib on mitochondrial function in isolated rat heart mitochondria and H9c2 cells. Toxicol. Sci. 2008, 106:153-161.
127. Zeidán Q., Strauss M., Porras N., Anselmi G. Differential long-term subcellular responses in heart and liver to adriamycin stress. Exogenous l-carnitine cardiac and hepatic protection. J. Submicrosc. Cytol. Pathol. 2002, 34:315-321.
128. Zhang Y., Ren J. Thapsigargin triggers cardiac contractile dysfunction via NADPH oxidase-mediated mitochondrial dysfunction: Role of Akt dephosphorylation. Free Radic. Biol. Med. 2011, 51:2172-2184.
129. Zhao Y., Xie P., Tang R., Zhang X., Li L., Li D. In vivo studies on the toxic effects of microcystins on mitochondrial electron transport chain and ion regulation in liver and heart of rabbit. Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 2008, 148:204-210.
130. Zhu B., Zhu Z.N., Wang J.Z., Huang S.M., Feng X.M., Li A.Y., Yang D.L., Wang B.J. Assessment of mitochondrial toxicity induced by zidovudine and adefovir dipivoxil in rats. Zhonghua Gan Zang Bing Za Zhi 2012, 20:794-797.